Frontlight ResearchEarly access
Active, not recruitingNo phase
PICS: Subtitle Cardiac Dysfunction in Older Sepsis Survivors
Key facts
- Who runs it
- University of Florida
- Where
- Gainesville, United StatesSee the site
- Trial code
- Status
- Active, not recruiting
- People taking part
- 668 people enrolled
- Started
- Jan 2015
- Expected to end
- 24 Jul 2027
- Type of study
- Observational, 2 groups
- Treatments tested
- Blood collection
- Urine collection
- Bioimpedance Analysis
- Cognitive Function Tests
- Quality-of-life Questionnaires
- Physical Function Tests
- Record updated
- 9 September 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 27 criteriaShow less
Who can take part
- presence in the surgery or trauma intensive care unit (ICU) at University of Florida (UF) Health Shands Hospital where clinical care can be managed by surgical critical care guided by standard operating procedures
- age of ≥18 years
- placed on EMR sepsis protocol with sepsis/septic shock by Sepsis-3 criteriad
- ability to obtain informed consent
- all adults (age ≥18)
- Ability to obtain Informed Consent prior to blood collection
Who cannot take part
- organ transplant recipient on immunosuppressive agents
- interfacility transfer patients with > 96 hour critical illness prior to transfer
- Current, chronic steroid use
- uncontrollable source of sepsis (e.g., irreversible disease state such as unresectable dead bowel)
- severe Congestive Heart Failure (CHF) (NY Heart Association Class IV)
- severe chronic liver disease (Childs-Pugh Class B/C and /or MELD > 14) or pre-liver transplant
- pre-existing state of Chronic critical illness (ICU LOS ≥ 14 days, includes outside facility)
- known HIV infection with CD4 count <200 cells/mm3
- patients deemed to be futile care or have advanced care directives or goals of care limiting resuscitative efforts
- severe traumatic brain injury (evidence of neurologic injury on CT scan and a Glasgow Coma Scale (GCS) <8 after resuscitation)
- refractory shock (i.e., patients who die within 12 hours)
- known pregnancy
- prisoners
- institutionalized patients
- inability to obtain informed consent
- pre-hospital bedridden status (WHO/Zubrod score ≥ 4)
- patient's with an exacerbation of historic CVD or new onset CVD
- alternative or confounding diagnosis causing shock state (e.g. MI or PE)
- enrollment > 96 hours after suspected sepsis onset
- subsequent clinical adjudication not consistent with sepsis/septic shock by Sepsis-3 criteria; Healthy Controls
- Pregnancy
Where in United States
- UF Health Shands HospitalGainesville, United States
About the trial
What the trial wants to find out
The purpose of this study is to define the natural history and causes of chronic critical illness (CCI) in surgical intensive care patients who have had sepsis. The investigator also wants to define the long-term physical and cognitive outcomes of this disease. The investigator will be looking at many clinical variables to try to define CCI.
The 2 groups in the trial
- Sepsis
Blood Collection. Urine collection. Bioimpedance analysis. Quality-of-life questionnaires, physical function tests and cognitive function tests.
Treatment: Blood collection, Urine collection, Bioimpedance Analysis, Cognitive Function Tests, Quality-of-life Questionnaires, and Physical Function Tests
- Healthy Controls
Blood Collection.
Treatment: Blood Collection
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS): A New Horizon for Surgical Critical Care Subtitle: Cardiac Dysfunction in Older Sepsis Survivors Subtitle: Development of a Designer Proline-Rich Antimicrobial Peptide Chaperone Protein Inhibitor (DPC) for Treating Sepsis
- Publications
- Unique lymphocyte transcriptomic profiles in septic patients with chronic critical illness.Frontiers in immunology, 2024
- TRANSCRIPTOMIC DIFFERENCES IN PERIPHERAL MONOCYTE POPULATIONS IN SEPTIC PATIENTS BASED ON OUTCOME.Shock (Augusta, Ga.), 2024
- The post-septic peripheral myeloid compartment reveals unexpected diversity in myeloid-derived suppressor cells.Frontiers in immunology, 2024
- Phenotypic heterogeneity by site of infection in surgical sepsis: a prospective longitudinal study.Critical care (London, England), 2020
- Myeloid-derived suppressor cell function and epigenetic expression evolves over time after surgical sepsis.Critical care (London, England), 2019
- Persistently Elevated Glucagon-Like Peptide-1 Levels among Critically Ill Surgical Patients after Sepsis and Development of Chronic Critical Illness and Dismal Long-Term Outcomes.Journal of the American College of Surgeons, 2019
- The Development of Chronic Critical Illness Determines Physical Function, Quality of Life, and Long-Term Survival Among Early Survivors of Sepsis in Surgical ICUs.Critical care medicine, 2019
- Benchmarking clinical outcomes and the immunocatabolic phenotype of chronic critical illness after sepsis in surgical intensive care unit patients.The journal of trauma and acute care surgery, 2018
- Record updated
- 9 September 2026